Claims
- 1. In a grafting reaction system comprising a solid activated polymer and a liquid grafting medium containing a monomer, said system containing free radicals, the improvement wherein said system further comprises from 0.1 to 2% by weight of the grafting medium of a homopolymerization inhibitor compound, said inhibitor compound comprising a compatibilizing function toward the grafting medium, said compatibilizing function selected from the group consisting of sulfonic and carboxylic groups and an inhibiting function which acts as a transfer agent for said free radicals, said inhibiting function being an allyl or methallyl unsaturated group, said inhibitor compound having a diffusing capacity through said grafting medium which is greater than its diffusing capacity through said polymer.
- 2. System as claimed in claim 1 wherein the allyl or methallyl unsaturated group is the 2-methyl-propene group.
- 3. System as claimed in claim 1 wherein the inhibitor compound is sodium 2-methyl-2-propene sulfonate.
- 4. System as claimed in claim 1 wherein the inhibitor compound is sodium-4-(2-methyl-2-propene-yl)-benzene sulfonate.
- 5. System as claimed in claim 1 wherein the inhibitor compound is allyl acetate.
- 6. System as claimed in claim 1 wherein the grafting medium contains acrylamide or acrylic acid as said monomer.
- 7. In a grafting process comprising reacting a solid activated polymer with a monomer contained in a liquid grafting medium, in the presence of free radicals, the improvement comprising inhibiting homopolymerization of said monomer by reacting said activated polymer and monomer in the presence of from 0.1% to 2% by weight of the grafting medium of a homopolymerization inhibitor compound, said inhibitor compound comprising a compatibilizing function toward the grafting medium, said compatibilizing function selected from the group consisting of sulfonic and carboxylic groups and an inhibiting function which acts as a transfer agent for said free radicals, said inhibiting function being an allyl or methallyl unsaturated group, said inhibitor compound having a diffusing capacity through said grafting medium which is greater than its diffusing capacity through said polymer.
- 8. Process as claimed in claim 7 wherein the allyl or methallyl group is the 2-methyl propene group.
- 9. Process as claimed in claim 8 wherein the inhibitor compound is sodium 2-methyl-2-propene sulfonate.
- 10. Process as claimed in claim 2 wherein the inhibitor compound is sodium 4-(2-methyl-2-propene-yl)-benzene sulfonate.
- 11. Process as claimed in claim 7 wherein the inhibitor compound is allyl acetate.
- 12. Process as claimed in claim 7 wherein the grafting medium contains acrylamide or acrylic acid as said monomer.
- 13. Process for inhibiting monomer homopolymerization in a grafting reaction of an activated polymer and monomer, comprising: forming a liquid grafting medium containing a monomer and a homopolymerization inhibitor compound comprising a compatibilizing function toward the grafting medium, said compatibilizing function selected from the group consisting of sulfonic and carboxylic groups, and an inhibiting function which acts as a transfer agent for free radicals, said inhibiting function being an allyl or methallyl unsaturated group, said inhibitor compound having a diffusing capacity through said grafting medium which is greater than its diffusing capacity through said polymer; adding to said medium an activated solid polymer; and reacting said activated solid polymer and said monomer in the presence of said homopolymerization inhibitor compound, wherein said homopolymerization inhibitor compound is present at a level of 0.1-2% by weight of the grafting medium and monomer.
- 14. Process as claimed in claim 13 wherein the allyl or methallyl group is the 2-methyl propene group.
- 15. Process as claimed in claim 14 wherein the inhibitor compound is sodium 2-methyl-2-propene sulfonate.
- 16. Process as claimed in claim 13 wherein the inhibitor compound is sodium 4-(2-methyl-2-propene-yl)-benzene sulfonate.
- 17. Process as claimed in claim 13 wherein the inhibitor compound is allyl acetate.
- 18. Process as claimed in claim 13 wherein the grafting medium contains acrylamide or acrylic acid as said monomer.
Priority Claims (1)
Number |
Date |
Country |
Kind |
85 17612 |
Nov 1985 |
FRX |
|
Parent Case Info
This application is a continuation-in-part of U.S. patent application Ser. No. 159,512, filed Feb. 18, 1988, which is a continuation of U.S. patent application Ser. No. 935,837, filed Nov. 28, 1986, both now abandoned.
US Referenced Citations (9)
Foreign Referenced Citations (2)
Number |
Date |
Country |
853971 |
Nov 1960 |
GBX |
876535 |
Sep 1961 |
GBX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
935837 |
Nov 1986 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
159512 |
Feb 1988 |
|